Modalis Therapeutics
About:
Modalis is a biotech company that develops therapeutics using CRISPR based technology.
Website: http://www.modalistx.com/jp
Twitter/X: modalistx
Top Investors: Mitsubishi UFJ Capital, SMBC Venture Capital, SBI Investment, Mizuho Capital, UTokyo Innovation Platform
Description:
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
$38.5M
$10M to $50M
Tokyo, Tokyo, Japan
2016-01-01
otoiawase(AT)modalistx.com
Haru Morita, Osamu Nureki
11-50
2019-04-10
Public
© 2025 bioDAO.ai